(2) Drug testing: Organoids cultured from prostate cancer patients have demonstrated resistance to cell growth arrest and apoptosis induced by BET inhibitors, revealing a new molecular mechanism for BET inhibitor resistance in these patients [135,136]. Here, DNER is linked to prostate cancer.